Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trends
Parkinson’s disease (PD) is a neurodegenerative disorder that significantly impacts patients’ quality of life. Managing PD requires accurate assessment of motor and non-motor symptoms, often complicated by the subjectivity in symptom reporting and the limited availability of neurologists. To address...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1470928/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846111757391626240 |
|---|---|
| author | Daniel Rodríguez-Martín Carlos Pérez-López Carlos Pérez-López |
| author_facet | Daniel Rodríguez-Martín Carlos Pérez-López Carlos Pérez-López |
| author_sort | Daniel Rodríguez-Martín |
| collection | DOAJ |
| description | Parkinson’s disease (PD) is a neurodegenerative disorder that significantly impacts patients’ quality of life. Managing PD requires accurate assessment of motor and non-motor symptoms, often complicated by the subjectivity in symptom reporting and the limited availability of neurologists. To address these challenges, commercial wearable devices have emerged to continuously monitor PD symptoms outside the clinical setting. The main devices include PKG™, Kinesia 360™, Kinesia U™, PDMonitor™, and STAT-ON™. These devices utilize advanced technologies such as accelerometers, gyroscopes, and specific algorithms to provide objective data on motor symptoms like tremors, dyskinesia, and bradykinesia. Despite their potential, the adoption of these devices is limited due to concerns about their accuracy, complexity of use, and lack of independent validation. The correlation between these devices’ measurements and traditional clinical observations varies, and patient usability and adherence remain critical areas for improvement. To optimize their utility and improve patient outcomes, it is essential to conduct validation and usability studies with a sufficient number of patients, develop standardized protocols, and ensure integration with hospital information systems. |
| format | Article |
| id | doaj-art-58e989f39c984e75b39dba14c3892eac |
| institution | Kabale University |
| issn | 1664-2295 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj-art-58e989f39c984e75b39dba14c3892eac2024-12-23T05:10:18ZengFrontiers Media S.A.Frontiers in Neurology1664-22952024-12-011510.3389/fneur.2024.14709281470928Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trendsDaniel Rodríguez-Martín0Carlos Pérez-López1Carlos Pérez-López2Sense4Care, Cornellà de Llobregat, SpainSense4Care, Cornellà de Llobregat, SpainConsorci Sanitari Alt Penedès-Garraf, Vilanova i la Geltrú, SpainParkinson’s disease (PD) is a neurodegenerative disorder that significantly impacts patients’ quality of life. Managing PD requires accurate assessment of motor and non-motor symptoms, often complicated by the subjectivity in symptom reporting and the limited availability of neurologists. To address these challenges, commercial wearable devices have emerged to continuously monitor PD symptoms outside the clinical setting. The main devices include PKG™, Kinesia 360™, Kinesia U™, PDMonitor™, and STAT-ON™. These devices utilize advanced technologies such as accelerometers, gyroscopes, and specific algorithms to provide objective data on motor symptoms like tremors, dyskinesia, and bradykinesia. Despite their potential, the adoption of these devices is limited due to concerns about their accuracy, complexity of use, and lack of independent validation. The correlation between these devices’ measurements and traditional clinical observations varies, and patient usability and adherence remain critical areas for improvement. To optimize their utility and improve patient outcomes, it is essential to conduct validation and usability studies with a sufficient number of patients, develop standardized protocols, and ensure integration with hospital information systems.https://www.frontiersin.org/articles/10.3389/fneur.2024.1470928/fullwearablesmotor symptomsearly detectionmedical devicesobjective evaluation |
| spellingShingle | Daniel Rodríguez-Martín Carlos Pérez-López Carlos Pérez-López Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trends Frontiers in Neurology wearables motor symptoms early detection medical devices objective evaluation |
| title | Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trends |
| title_full | Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trends |
| title_fullStr | Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trends |
| title_full_unstemmed | Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trends |
| title_short | Commercial symptom monitoring devices in Parkinson’s disease: benefits, limitations, and trends |
| title_sort | commercial symptom monitoring devices in parkinson s disease benefits limitations and trends |
| topic | wearables motor symptoms early detection medical devices objective evaluation |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2024.1470928/full |
| work_keys_str_mv | AT danielrodriguezmartin commercialsymptommonitoringdevicesinparkinsonsdiseasebenefitslimitationsandtrends AT carlosperezlopez commercialsymptommonitoringdevicesinparkinsonsdiseasebenefitslimitationsandtrends AT carlosperezlopez commercialsymptommonitoringdevicesinparkinsonsdiseasebenefitslimitationsandtrends |